Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M et al (2022) Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 66:15–23

Article  PubMed  PubMed Central  Google Scholar 

Early Breast Cancer Trialists’ Collaborative G, Darby S, McGale P, Correa C, Taylor C, Arriagada R, et al. 2011 Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 378(9804):1707–16

Ebctcg. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. The Lancet. 2014: 383(9935):2127–35

Whelan T, MacKenzie R, Julian J, Levine M, Shelley W, Grimard L et al (2002) Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. JNCI J National Cancer Inst 94(15):1143–50

Article  Google Scholar 

Yang J, Qi SN, Fang H, Song YW, Jin J, Liu YP et al (2021) Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancer. Breast 58:72–79

Article  PubMed  PubMed Central  Google Scholar 

Delaney G, Barton M, Jacob S (2003) Estimation of an optimal radiotherapy utilization rate for breast carcinoma: a review of the evidence. Cancer 98(9):1977–1986

Article  PubMed  Google Scholar 

Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ et al (2013) The UK standardisation of breast radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 14(11):1086–1094

Article  PubMed  Google Scholar 

Wang SL, Fang H, Song YW, Wang WH, Hu C, Liu YP et al (2019) Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised non-inferiority open-label phase 3 trial. Lancet Oncol 20(3):352–360

Article  PubMed  Google Scholar 

Yadav BS, Bansal A, Kuttikat PG, Das D, Gupta A, Dahiya D (2020) Late-term effects of hypofractionated chest wall and regional nodal radiotherapy with two-dimensional technique in patients with breast cancer. Radiat Oncol J 38(2):109–118

Article  PubMed  PubMed Central  Google Scholar 

Cao L, Kirova YM, Shen KW, Xu C, Chen JY. 2019 Clinical impact of delaying initiation of radiotherapy after definitive surgery or adjuvant chemotherapy in breast cancer patients. I J Radiation Oncology*Biology*Physics. 105(1)

Lamm R, Woodward SG, Varshney K, Lyons W, Anne PR, George BJ, Willis AI (2022) A comparison of timely completion of hypofractionated and traditional adjuvant radiation therapy in early-stage breast cancer: evidence of impact on reducing racial and socioeconomic disparities. Surgery 172(1):31–40

Article  PubMed  Google Scholar 

Tovanabutra C, Katanyoo K, Uber P, Chomprasert K, Sukauichai S (2020) Comparison of treatment outcome between hypofractionated radiotherapy and conventional radiotherapy in postmastectomy breast cancer. Asian Pac J Cancer Prev 21(1):119–125

Article  PubMed  PubMed Central  Google Scholar 

Bochenek-Cibor J, Georgiew F, Goyal S (2020) A retrospective analysis on safety and effectiveness of hypofractioned post-mastectomy radiotherapy. Breast J 26(2):176–181

Article  PubMed  Google Scholar 

Pinitpatcharalert A, Chitapanarux I, Euathrongchit J, Tharavichitkul E, Sukthomya V, Lorvidhaya V (2011) A retrospective study comparing hypofractionated radiotherapy and conventional radiotherapy in postmastectomy breast cancer. J Med Assoc Thai 94(Suppl 2):S94-102

PubMed  Google Scholar 

Liu L, Yang Y, Guo Q, Ren B, Peng Q, Zou L et al (2020) Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review. Radiat Oncol 15(1):17

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raveendran C, Meloot SS, Yadev I (2023) Survival outcomes of post-mastectomy breast cancer patients treated with hypofractionated radiation treatment compared to conventional fractionation - a retrospective cohort study. Gulf J Oncolog 1(42):26–34

PubMed  Google Scholar 

Sun JY, Wu SG, Li S, Li FY, Chen WF, Lin Q, He ZY (2013) Locoregional recurrence of pT3N0M0 breast cancer after mastectomy is not higher than that of pT1-2N0M0: an analysis for radiotherapy. Cancer Sci 104(5):599–603

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kheradmand AA, Ranjbarnovin N, Khazaeipour Z (2010) Postmastectomy locoregional recurrence and recurrence-free survival in breast cancer patients. World J Surg Oncol 8(1):30

Article  PubMed  PubMed Central  Google Scholar 

Team RC. 2020 R: A language and environment for statistical computing. 4.0.2 ed. Vienna Austria: R Foundation for Statistical Computing

Koulis TA, Nichol AM, Truong PT, Speers C, Gondara L, Tyldesley S et al (2020) Hypofractionated adjuvant radiation therapy is effective for patients with lymph node-positive breast cancer: a population-based analysis. Int J Radiat Oncol Biol Phys 108(5):1150–1158

Article  PubMed  Google Scholar 

Rosenberger LH, Ren Y, Thomas SM, Greenup RA, Fayanju OM, Hwang ES, Plichta JK (2020) Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough? Breast Cancer Res Treat 179(3):661–670

Article  CAS  PubMed  Google Scholar 

Ebner F, Wockel A, Schwentner L, Blettner M, Janni W, Kreienberg R, Wischnewsky M (2019) Does the number of removed axillary lymphnodes in high risk breast cancer patients influence the survival? BMC Cancer 19(1):90

Article  PubMed  PubMed Central  Google Scholar 

Abass MO, Gismalla MDA, Alsheikh AA, Elhassan MMA (2018) Axillary lymph node dissection for breast cancer: efficacy and complication in developing countries. J Glob Oncol 4:1–8

PubMed  Google Scholar 

Early Breast Cancer Trialists’ Collaborative Group. Electronic address bocoau Early Breast Cancer Trialists’ Collaborative G. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100,000 women from 86 randomised trials. Lancet. 2023 401(10384):1277–92

Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F et al (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337(14):949–55

Article  CAS  PubMed  Google Scholar 

Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A et al (2015) Regional nodal irradiation in early-stage breast cancer. N Engl J Med 373(4):307–316

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chitapanarux I, Klunklin P, Pinitpatcharalert A, Sripan P, Tharavichitkul E, Nobnop W et al (2019) Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity. Radiat Oncol 14(1):175

Article  PubMed  PubMed Central  Google Scholar 

Benolken MM, McLaughlin S, Piltin M, Mrdutt M, Li Z, Jakub JW (2023) Lymph node positivity of axillary reverse mapping lymph nodes at the time of axillary lymph node dissection: two-site prospective trial. Ann Surg Oncol 30(10):6042–6049

Article  PubMed  Google Scholar 

Harahap WA, Nindrea RD (2019) Prognostic factors of local-regional recurrence in patients with operable breast cancer in Asia: a meta-analysis. Open Access Maced J Med Sci 7(4):690–695

Article  PubMed  PubMed Central  Google Scholar 

Shah C, Hobbs BP, Vicini F, Al-Hilli Z, Manyam BV, Verma V et al (2020) The diminishing impact of margin definitions and width on local recurrence rates following breast-conserving therapy for early-stage invasive cancer: a meta-analysis. Ann Surg Oncol 27(12):4628–4636

Article  PubMed  Google Scholar 

Yoon TI, Lee JW, Lee SB, Sohn G, Kim J, Chung IY et al (2018) No association of positive superficial and/or deep margins with local recurrence in invasive breast cancer treated with breast-conserving surgery. Cancer Res Treat 50(1):275–282

Article  PubMed  Google Scholar